Clinical trial Recruiting at 4 sites Interventional Ages 18 and up

High-flow nasal oxygen versus regular oxygen during awake intubation for difficult airways

Official title: High-Flow Nasal Cannula Versus Conventional Oxygen to Prevent Hypoxaemia During Awake Tracheal Intubation: A Multicentre, Open-Label, Randomised Controlled Trial (OXYOPTI-ATI)

Run by Eye & ENT Hospital of Fudan University · NCT07384494 · Data updated 2026-11-12

This trial will test whether high-flow nasal oxygen helps adults with anticipated difficult airways keep their oxygen levels safer during awake tracheal intubation compared with conventional low-flow oxygen.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment336 (estimated)
SponsorEye & ENT Hospital of Fudan University
Academic / other
Locations6 sites (Wuwei, Gansu and 5 other locations)
StatusRecruiting
StartedFebruary 4, 2026
Main results expectedFebruary 4, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 28, 2026
Trial IDNCT07384494 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18 years) with an anticipated difficult airway who are planned for awake tracheal intubation and can provide informed consent.

Probably not a fit

Patients with contraindications to high-flow nasal cannula (severe nasal obstruction, recent nasal/skull base surgery, skull base fracture, active epistaxis), hemodynamic instability, pregnancy, or those already in another interventional trial are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with an anticipated difficult airway who are scheduled for awake tracheal intubation will be assigned to receive either high-flow nasal cannula oxygen or conventional low-flow nasal oxygen during the procedure. The protocol preserves spontaneous breathing and monitors oxygenation throughout intubation, with hypoxemia incidence and related complications as key outcomes. Standard airway management techniques are used alongside the assigned oxygen therapy to compare safety and stability during awake intubation. Data will be collected at multiple participating hospitals in China and analyzed to determine differences in desaturation and procedure-related adverse events.

Why it matters

Potential benefit: If successful, this approach could reduce episodes of low oxygen during awake intubation and lower the risk of serious complications from hypoxemia.

How similar studies have gone: Prior clinical work has suggested high-flow nasal oxygen can reduce desaturation during airway management and apneic periods, but evidence specifically in awake tracheal intubation is limited and not yet definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Presence of an anticipated difficult airway;
* Planned awake tracheal intubation;
* Age ≥ 18 years;
* Willingness to participate in the study and provision of written informed consent.

Exclusion Criteria:

* Contraindications to HFNC use, such as severe nasal obstruction or deformity, recent (within 3 months) nasal or skull base surgery, skull base fracture, or active epistaxis;
* Hemodynamic instability, defined as a mean arterial pressure (MAP) \< 65 mmHg or the need for vasoactive medications to maintain blood pressure;
* Pregnancy;
* Current participation in another interventional clinical trial.

Where it's running

  • Wuwei People's Hospital
    Wuwei, Gansu, China
    Recruiting
  • South China Hospital of Shenzhen University
    Shenzhen, Guangzhou, China
    Recruiting
  • Pizhou Hospital of Traditional Chinese Medicine
    Pizhou, Jiangsu, China
    Recruiting
  • Eye & ENT Hospital of Fudan University
    Shanghai, Shanghai Municipality, China
    Recruiting
  • Baoding No.1 Central Hospital
    Baoding, Hebei, China
    Not yet recruiting
  • The First People's Hospital of Neijiang
    Neijiang, Sichuan, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.